GLP-1 drugs like Ozempic and Mounjaro are changing the weight loss landscape. Appetite drops, food noise quiets, and for many people, the scale finally starts moving.

In this episode, Paul Bassett shares a practical, front-line perspective on what happens when clients start using GLP-1 medications. Not from a medical standpoint, but from the reality of coaching people who are on them, considering them, or coming off them.

This episode explores where GLP-1 can create opportunity, where it falls short, and why strength training, habits, and culture still determine whether the results last. It’s a grounded discussion about momentum, muscle mass, rebound risk, and what real ownership of your health looks like. 

⸻

In This Episode, You’ll Learn:

• What GLP-1 drugs actually change in day-to-day life

• Why reduced appetite doesn’t automatically mean better health

• The muscle loss risk and why strength training matters

• The rebound problem when coming off medication

• Why weight loss and body transformation are not the same

• How to use GLP-1 as a tool rather than a dependency

• The simple habits that still drive long-term results

⸻

Who This Episode Is For:

• Anyone considering Ozempic, Mounjaro, or other GLP-1 drugs

• Clients currently using GLP-1 and unsure what to focus on

• People frustrated by repeated fat loss cycles

• Busy adults wanting sustainable results

• Anyone who wants clarity without judgement

⸻

About the Show

Beast of Burden is a weekly podcast hosted by Paul Bassett, founder of Hounds of Health in Wandsworth, London. The show focuses on strength, fitness, mindset, and accountability for people who want sustainable progress rather than quick fixes.

Each episode is grounded in real coaching experience, not trends or hype.

⸻

Connect & Learn More

To learn more about coaching with Hounds of Health or to talk through your goals:

Website: https://www.houndsofhealth.co.uk

Instagram: https://www.instagram.com/houndsofhealth

Enquiries: [email protected]